Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshitaka Inoue

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Annals of Hematology|October 13, 2025
Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxisNatasha Venugopal, Andrew McGowan, Yoshitaka Inoue, et al.
British Journal of Haematology|June 19, 2025
Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantationClaudia Mae Velasco, Yoshitaka Inoue, Joseph Cioccio, et al.
Molecular Cancer Therapeutics|April 22, 2026
TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy StudiesYuka Hoshi-Kadonosawa, William C Reinhold, Daiki Taniyama, et al.
Bone Marrow Transplantation|March 25, 2023
The clinical benefit of acute GVHD depends on the age at transplantation in patients with adult T-cell leukemia-lymphoma on behalf of the ATL Working Group of the Japan Society for Transplantation and Cellular TherapyShigeo Fuji, Yoshitaka Inoue, Junya Makiyama, et al.
Bone Marrow Transplantation|May 12, 2023
Impact of HLA-mismatched unrelated transplantation in patients with adult T-cell leukemia/lymphomaYoshitaka Inoue, Satoko Morishima, Koji Kato, et al.
Blood Transfusion = Trasfusione Del Sangue|October 24, 2024
Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02Akshita Khosla, Yoshitaka Inoue, Joseph Cioccio, et al.
Transplantation and Cellular Therapy|July 18, 2021
A Phase I/II Multicenter Trial of HLA-Haploidentical PBSCT with PTCy for Aggressive Adult T Cell Leukemia/LymphomaTakashi Tanaka, Hirohisa Nakamae, Ayumu Ito, et al.
The Journal of Molecular Diagnostics : JMD|November 27, 2024
Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed ChimerismRuoheng Zhang, Yimeng Shang, Joseph Cioccio, et al.
Annals of Hematology|June 20, 2023
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working GroupMasuho Saburi, Kumi Oshima, Kuniko Takano, et al.
Leukemia Research|June 9, 2024
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantationEmma Zulch, Yoshitaka Inoue, Joseph Cioccio, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Annals of Hematology|October 13, 2025
Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxisNatasha Venugopal, Andrew McGowan, Yoshitaka Inoue, et al.
British Journal of Haematology|June 19, 2025
Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantationClaudia Mae Velasco, Yoshitaka Inoue, Joseph Cioccio, et al.
Molecular Cancer Therapeutics|April 22, 2026
TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy StudiesYuka Hoshi-Kadonosawa, William C Reinhold, Daiki Taniyama, et al.
Bone Marrow Transplantation|March 25, 2023
The clinical benefit of acute GVHD depends on the age at transplantation in patients with adult T-cell leukemia-lymphoma on behalf of the ATL Working Group of the Japan Society for Transplantation and Cellular TherapyShigeo Fuji, Yoshitaka Inoue, Junya Makiyama, et al.
Bone Marrow Transplantation|May 12, 2023
Impact of HLA-mismatched unrelated transplantation in patients with adult T-cell leukemia/lymphomaYoshitaka Inoue, Satoko Morishima, Koji Kato, et al.
Blood Transfusion = Trasfusione Del Sangue|October 24, 2024
Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02Akshita Khosla, Yoshitaka Inoue, Joseph Cioccio, et al.
Transplantation and Cellular Therapy|July 18, 2021
A Phase I/II Multicenter Trial of HLA-Haploidentical PBSCT with PTCy for Aggressive Adult T Cell Leukemia/LymphomaTakashi Tanaka, Hirohisa Nakamae, Ayumu Ito, et al.
The Journal of Molecular Diagnostics : JMD|November 27, 2024
Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed ChimerismRuoheng Zhang, Yimeng Shang, Joseph Cioccio, et al.
Annals of Hematology|June 20, 2023
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working GroupMasuho Saburi, Kumi Oshima, Kuniko Takano, et al.
Leukemia Research|June 9, 2024
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantationEmma Zulch, Yoshitaka Inoue, Joseph Cioccio, et al.
Pageof 7